怡康泰工程集團(08445.HK)前三季度由盈轉虧至1361.2萬港元
格隆匯2月14日丨怡康泰工程集團(08445.HK)公吿,截至2021年12月31日止9個月,2.36億港元,同比減少2.57%;公司擁有人應占期內虧損1361.2萬港元,去年則盈利118.3萬港元,盈轉虧;每股虧損0.071港元。
淨虧損主要可歸因於毛利減少。展望未來,新型冠狀病毒(COVID-19)持續於香港爆發於不遠的將來對建築業的現金流、營運效率及若干項目的完成進度繼續造成不利影響。
儘管短期內行業面臨諸多挑戰及不確定性,仍將不忘長遠目標及可持續發展。董事會將採取適當措施提升經營效率,並積極投取具盈利的項目,以減輕對集團造成的任何不利影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.